- $1.17bn
- $1.15bn
- $1.31bn
- 58
- 70
- 58
- 64
Annual balance sheet for Revelyst, fiscal year end - March 31st, millions except per share.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | — | 15.5 | 22.9 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | — | 202 | 211 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | — | 664 | 557 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 171 | 161 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | — | 1,951 | 1,575 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 204 | 206 |
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 365 | 341 |
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | — | 1,586 | 1,234 |
| Total Liabilities & Shareholders' Equity | — | 1,951 | 1,575 |
| Total Common Shares Outstanding |